Carroll Financial Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $348K | Sell |
|
|||||
|
2021
Q3 | $623K | Buy |
|
|||||
|
2021
Q2 | $593K | Sell |
|
|||||
|
2021
Q1 | $625K | Sell |
|
|||||
|
2020
Q4 | $582K | Sell |
|
|||||
|
2020
Q3 | $692K | Buy |
|
|||||
|
2020
Q2 | $818K | Sell |
|
|||||
|
2020
Q1 | $1.06M | Buy |
|
|||||
|
2019
Q4 | $222K | Sell |
|
|||||
|
2019
Q3 | $362K | Buy |
|
|||||
|
2019
Q2 | $266K | Buy |
|
|||||
|
2019
Q1 | $209K | Buy |
|
|||||
|
2018
Q4 | $198K | Buy |
|
|||||
|
2018
Q3 | $222K | Sell |
|
|||||
|
2018
Q2 | $226K | Buy |
|
|||||
|
2018
Q1 | $193K | Buy |
|
|||||
|
2017
Q4 | $182K | Sell |
|
|||||
|
2017
Q3 | $376K | Sell |
|
|||||
|
2017
Q2 | $329K | Buy |
|
|||||
|
2017
Q1 | $312K | Sell |
|
|||||
|
2016
Q4 | $365K | Sell |
|
|||||
|
2016
Q3 | $414K | Buy |
|
|||||
|
2016
Q2 | $406K | Buy |
|
|||||
|
2016
Q1 | $442K | Buy |
|
|||||
|
2015
Q4 | $454K | Sell |
|
|||||
|
2015
Q3 | $474K | Buy |
|
|||||
|
2015
Q2 | $507K | Buy |
|
|||||
|
2015
Q1 | $132K | Buy |
|
|||||
|
2014
Q4 | $128K | Sell |
|
|||||
|
2014
Q3 | $414K | Buy |
|
|||||
|
2014
Q2 | $259K | Buy |
|
|||||
|
2014
Q1 | $211K | Buy |
|
|||||
|
2013
Q4 | $216K | Buy |
|
|||||
|
2013
Q3 | $172K | Buy |
|
|||||
|
2013
Q2 | $119K | Buy |
|